Trillions of bacteria, collectively referred to as the microbiota, reside in gastrointestinal tract
INTRODUCTION

History of the stomach colonization by Helicobacter pylori
Trillions of bacteria, collectively referred to as the microbiota, reside in the gastrointestinal tract, Helicobacter (Campylobacter) pylori (H. pylori) being a member of this microbial society. In 1983 and 1984 Lancet published the first papers of two Australian physicians, Marshall and Warren (1, 2) , demonstrating H. pylori infection in biopsy specimens from patients with gastritis. In paper published in 1985, Marshall and colleagues (3) reported a personal experiment using oral administration of H. pylori suspension by Dr Marshall himself, resulted in the development of gastritis shortly after
METABOLOGY OF HELICOBACTER PYLORI INFECTION: ROLE OF GASTROKINES
Wei, Bai, Tonchev, Stankulov, and Chaldakov infection (see also 4). In fact, the presence of spirochete-like bacteria in the stomach has been recognized since 1892 (see 5) (Table 1 ).
Here we Dance Round possible role of gastrokines in metabolic pathways and food intake as related to cardiometabolic diseases associated with H. pylori infection or its eradication.
H. PYLORI INFECTION AND GASTOKINES
Biology of H. pylori
H. pylori is a curved or spiral shaped Gram negative, mobile bacterium. It measures 3-5 µm in length and approximately 0.5 µm in diameter. H. pylori colonizes the stomachs of roughly half of the world's population and usually persists in the gastric mucosa of human hosts for decades or life. Family unit is generally accepted as one of the contributors to H. pylori infection that is most frequently acquired in childhood. Although most H. pylori-positive people are asymptomatic, the presence of H. pylori is associated with increased risk for the development of peptic ulcer disease, gastric adenocarcinoma and gastric lymphoma (reviewed in 5). The development of a sustained gastric inflammatory and immune response to H. pylori infection appears to play a pivotal role for the development of these diseases. During its long co-existence with humans, H. pylori has evolved complex strategies to maintain a low-grade inflammation of the gastric epithelium. Important local factors implicated in the pathobiology of H. pylori include urease-dependent NH 3 production and the bacterial cytotoxin associated gene A (CagA).
Gastrokines: what in the name?
Today, the number of "-kine" bioactive molecules as well as "-omics" sciences is dramatically increased. Generally referred to as cytokines and chemokines (Table 2) , various molecules, depending on the cellular source of their secretion (synthesis, store, and release), were more specifically dubbed adipokines (6-10), myokines (11, 12) or enterokines (13) . Here we introduce the term "gastrokines" to connote the bioactive molecules secreted by selected gastric cells, using both paraand endocrine pathway ( Table 3) .
The host's immune-inflammatory response, involving paracrine overproduction of pro-inflammatory cytokines such Modified from Chaldakov et al (6) . Note that all the listed mediators may also be secreted by adipose tissue cells (6-10,34-41). * FIZZ, found in inflammatory zone -a member of FIZZ family of secreted proteins ** Monocyte chemoattractant protein-1 (cysteine cysteine modif chemokine ligand) *** RANTES, regulated on activated normal T-cell expressed and secreted The discovery of adipokines (6-10) and gastrointestinal cellsecreted factors (24) (25) (26) (27) (28) (29) (30) promotes investigations of possible relationship among inflammation, obesity-related diseases, and H. pylori infection. Under healthy conditions, the gastrointestinal mucosa is in a state of "controlled inflammation" regulated by a delicate balance of pro-and anti-inflammatory mediators, examples being shown in Table 2 .
Metabology of H. pylori infection
H. pylori and gastric leptin
A selected list of gastro(entero)kines is presented in Table 3 , ghrelin and leptin being signature examples of these molecules (24) (25) (26) (27) (28) (29) (30) (36) (37) (38) (39) (40) (41) (42) (43) (44) . The "classical" leptin, an ob gene product, is adipocyte-secreted protein/cytokine (31) . Leptin, via its yin-yang action on specific hypothalamic neurons, exerts an anorexic effect also associated with acute and chronic inflammation (32) (33) (34) (35) . Gastric leptin, in tandem with a local pro-inflammatory cytokine/chemokine network, may be involved in local and systemic inflammatory response to H. pylori infection. Several studies have indeed found (positive or negative) relations between H. pylori and risk of obesity and related diseases. For instance, eradication of H. pylori is associated with (i) decreased gastric leptin levels and subsequent weight gain (19) , and (ii) an increase in both body mass index and cholesterol and triglyceride levels (40) . Moreover, H. pylori infection is associated with upregulation of adipocyte genes, including those encoding for leptin, adiponectin, and resistin; an adipocentric insight (6-10,29-35) into H. pylori infection is a matter of our ongoing work.
H. pylori and gastric ghrelin
Although several other potent orexigenic peptides, including neuropeptide tyrosine (NPY) and agouti-related peptide, have been characterized in the brain, ghrelin is the first appetitestimulating signal originating from the stomach (reviewed in 29, 30) . Ghrelin ("ghre", meaning grow) is a 28-amino acid peptide (3.3 kD) that is synthesized predominantly in mucosal endocrine cells called A-like cells, which are located in the gastric corpus. Ghrelin was discovered in 1999 (27) and named for its ability to stimulate growth hormone (GH) secretion via activation of GH secretagogue receptor (5, (28) (29) (30) . However, ghrelin is much more that simply a natural GH secretagogue. Contrary to leptin, ghrelin has profound orexigenic properties, increasing food intake and reducing fat utilization; likewise, it exerts many effects similar to those of endocannabinoids, known food-intake-stimulating molecules (30) . Altogether, leptin-ghrelin tango hypothesis of obesity was proposed (25; also 24, 26) ; it may also be danced during H. pylori infection. Note that a prolonged period of breastfeeding has been shown to reduced the risk of obesity development, whereas gastric and plasma ghrelin concentration are maintained at a lower level by delayed weaning in rats (28) .
Suzuki et al (5) studied the kinetics of ghrelin in animal model of H. pylori infection and found a gradual decrease in ghrelin-immunoreactive gastric cells, whereas clinical studies demonstrated that plasma ghrelin levels may be used as a marker for subjects at high risk of atrophic gastritis or gastric cancer. This remains to further be pursued in cardiometabolic disease (17) (18) (19) (20) (21) (22) (23) 45, 46) .
CONCLUSION
Cardiometabolic disease is multifactorial in nature. Here we discussed that one important factor that may affect the metabolic pathways of glucose and lipids and also food intake comprise an altered secretion of gastrokines possibly triggered by H. pylori infection. In perspective, a possible involvement of enterokines and adipokines, other essential dancers in metabolism, inflammation, and food intake, may also be studied. Further, a metagenomic (human genome and microbial genome/microbiome) approach (47, 48) to metabology of H. pylori infection may provide new insights into obesity and related cardiometabolic diseases.
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